Second eye gets gene therapy in bid to halt blindness
NCT ID NCT06646289
Summary
This study is testing the safety of a gene therapy injection for the second eye in people with X-linked retinitis pigmentosa, an inherited condition that causes vision loss. It is a follow-up for 24 adults and children who previously received the same treatment in their first eye in an earlier trial. The main goal is to see if treating the second eye is safe and if it helps improve or stabilize vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for X-LINKED RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, 02114, United States
-
Moorfields Eye Hospital
London, EC1V 2PD, United Kingdom
-
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan, 48105, United States
Conditions
Explore the condition pages connected to this study.